The IASLC is committed to providing you with a premier educational and professional experience at the IASLC 2020 World Conference on Lung Cancer (WCLC 2020). The association recognizes and respects the uncertainty that currently exists regarding the prospect of international travel and large-scale gatherings. However, the pace of progress for the understanding and treatment of lung cancer cannot stop. We are exploring virtual options for the effective sharing of educational content, including remote viewing options and the potential for remote and virtual presentations for those unable to attend.
I submitted an abstract prior to the original abstract submission deadline in March 2020, what happens now?
The status for all abstracts already submitted for WCLC 2020 Singapore will automatically be changed from ‘Submitted’ to ‘In Progress’, allowing you to choose ONE of the following options:
|Call for Abstracts||Now Open|
| Abstract Submission Deadline|
(includes Late-Breaking Abstract placeholders)
|August 28, 2020 (23:59 PST)|
|Education and Mentorship Awards Application Deadline||August 28, 2020 (23:59 PST)|
|Notification of Abstract Acceptance||October 9, 2020|
|Notification of Education and Mentorship Awards||October 9, 2020|
|Presenting Author and Abstract Title Changes Deadline||November 13, 2020|
|Presenting Author Registration Deadline||November 13, 2020|
|Late-Breaking Abstract Final Data Due||November 13, 2020|
|Late-Breaking Abstract Notifications||November 19, 2020|
|Abstract Titles Release Date||November 27, 2020|
|Oral and Mini Oral Presentation Slides Submission Deadline||December 18, 2020|
| Full Abstract Release |
(except for embargoed abstracts)
|January 4, 2021 (14:00 PST)|
|Poster and E-Poster Presentation Slides Submission Deadline||TBA|
Definition: Original scientific research that summarizes work done and major research findings.
Required sections for abstract submission:
Clinical Trials in Progress
Definition: Ongoing trials that have not reached pre-specified endpoints for analysis.
Case Report (eligible for designation as a poster or e-poster only)
Definition: Detailed report of symptoms, signs, diagnosis, treatment and follow up of an individual patient.
Required sections for abstract submission:
Late-Breaking Abstract (LBA) Submission
Definition: LBA designation will only be given to clinically relevant prospective studies in which data is not available at the time of abstract placeholder submission due to study timelines.
LBA designation is not a means for extending the regular abstract deadline. Any abstract that fails to meet LBA requirements will be designated as a regular abstract and rated based on the information available on the submission deadline.
Submission requirements: Authors of LBA must submit a place holder abstract through the abstract portal by August 28, 2020 (23:59 PST).
Required sections for place holder abstracts:
Review: The Scientific Program Committee will review LBA abstract placeholder applications. Authors of approved LBAs will be notified and instructed on deadlines and processes for submitting final data.
|Word Limit:||500 words (does not include title and authors)|
|Title Word Limit:||125 characters total (including spaces)|
|Tables:||No limit; each table counts as 100 words|
|Images:||2 maximum; each image counts as 100 words|
|Format(s):||Upload tables, images and graphs in GIF, JPEG, JPG or PNG format of a minimum of 300 dpi and 100% size. Higher resolution is acceptable and preferred.|
|Fee:||No submission fee|
|Submission Limit:||Presenters are limited to 2 oral presentations|
|Number of Co-authors:||No limit|
Encore Submission: An abstract that has previously been presented at another meeting will only be considered if there have been significant updates to the presentation. Submitters are required to list any previous presentations in the introduction of the abstract.
Author Information and Affirmations
Travel and Mentorship Awards
These awards are presented to individuals with high scoring abstracts who meet categorical eligibility criteria and who apply. Applications must be completed by the abstract submission deadline.
Independence of Educational Activities Policy
When will the Peer Review and Late-Breaking abstract titles and abstract body be published online?
January 6, 2021 (14:00 PST)
Does WCLC accept abstracts that have been submitted and presented to a previous Congress (ie, encore abstracts, trials in progress encore abstracts)?
An abstract that has previously been presented at another meeting will only be considered if there have been significant updates to the presentation. Submitters are required to list any previous presentations in the introduction of the abstract.
Are case reports/case series considered for presentations?
Yes, we do allow the submission of case reports.
What is the withdraw deadline for regular submissions and late breaking submissions?
Presenting author registration deadline is November 13, 2020. Any abstract presenters not registered by this date, their abstracts may be withdrawn from the program.
For late-breaking abstracts, does the congress only permit abstracts that report on Phase 3 [and higher] studies?
There are no guidelines/regulations as to which trials or studies can apply for late breaking privileges. We do not restrict late breaking privileges to ‘reports on Phase 3 (and higher) studies’.
Could I send my manuscript to publish to a journal in my country before WCLC?
If the abstract is published in a journal before WCLC, it may affect his rating. There are no rules that prevent submitters from having their abstract published in a journal before WCLC.
Is industry allowed to be in lead or senior author positions on the by-line for WCLC abstract submissions?
Yes, industry is allowed.
Does the restriction towards pharmaceutical/commercial authors apply to all abstracts submitted or is it just those accepted for oral and mini oral presentation?
Oral and Mini Oral presentations are prohibited from being presented by industry authors. The restriction does not apply for poster presentations since posters are not CME accredited.
Would it be possible to submit an abstract without results and conclusion?
You must submit a placeholder abstract by August 28, 2020. Please note abstracts submitted without results and conclusion may affect the rating of the abstract.
Is there a limit on the number of abstracts in which an author can be lead author?
There is no limit to the number of abstracts in which an author can be lead author. An individual may not be offered more than 2 oral presentations.
Is there any charge for the submission of abstracts, and if so, how much is it?
No, there is no charge to submit an abstract to WCLC.
For inquiries, please contact [email protected]. If your inquiry is regarding a particular draft or submission, please include the abstract ID in your email.
Keep up to date with Conference News & Alerts.
Save the Date
August 8, 2020
(7:00 am Denver time; 21:00 Singapore; 14:00 Vienna)